BioLargo Inc (BLGO)
OTHER OTC:BLGO
Want to see BLGO full AI Analyst Report?
Total Valuation
BioLargo has a market cap or net worth of $36.27M. The enterprise value is $36.83M.
Market Cap$36.27M
Enterprise Value$36.83M
Share Statistics
BioLargo has 320,883,270 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding320,883,270
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
BioLargo’s return on equity (ROE) is -2.91 and return on invested capital (ROIC) is -294.52%.
Return on Equity (ROE)-2.91
Return on Assets (ROA)-1.42
Return on Invested Capital (ROIC)-294.52%
Return on Capital Employed (ROCE)-4.57
Revenue Per Employee194.13K
Profits Per Employee-379.73K
Employee Count40
Asset Turnover0.93
Inventory Turnover14.06
Valuation Ratios
The current PE Ratio of BioLargo is ―. BioLargo’s PEG ratio is -0.01.
PE Ratio―
PS Ratio7.29
PB Ratio14.00
Price to Fair Value14.00
Price to FCF-6.78
Price to Operating Cash Flow-3.74
PEG Ratio-0.01
Income Statement
In the last 12 months, BioLargo had revenue of 7.76M and earned -11.78M in profits. Earnings per share was -0.04.
Revenue7.76M
Gross Profit3.41M
Operating Income-14.84M
Pretax Income-15.19M
Net Income-11.78M
EBITDA-14.55M
Earnings Per Share (EPS)-0.04
Cash Flow
In the last 12 months, operating cash flow was -9.38M and capital expenditures -78.00K, giving a free cash flow of -9.46M billion.
Operating Cash Flow-9.38M
Free Cash Flow-9.46M
Free Cash Flow per Share-0.03
Dividends & Yields
BioLargo pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.33
52-Week Price Change-44.88%
50-Day Moving Average0.13
200-Day Moving Average0.16
Relative Strength Index (RSI)43.19
Average Volume (3m)570.01K
Important Dates
BioLargo upcoming earnings date is Aug 18, 2026, TBA (Confirmed).
Last Earnings DateMay 20, 2026
Next Earnings DateAug 18, 2026
Ex-Dividend Date―
Financial Position
BioLargo as a current ratio of 1.01, with Debt / Equity ratio of 316.85%
Current Ratio1.01
Quick Ratio0.95
Debt to Market Cap0.04
Net Debt to EBITDA0.03
Interest Coverage Ratio-27.48
Taxes
In the past 12 months, BioLargo has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
BioLargo EV to EBITDA ratio is -3.86, with an EV/FCF ratio of -6.74.
EV to Sales7.24
EV to EBITDA-3.86
EV to Free Cash Flow-6.74
EV to Operating Cash Flow-6.77
Balance Sheet
BioLargo has $4.12M in cash and marketable securities with $5.66M in debt, giving a net cash position of -$1.54M billion.
Cash & Marketable Securities$4.12M
Total Debt$5.66M
Net Cash-$1.54M
Net Cash Per Share>-$0.01
Tangible Book Value Per Share<$0.01
Margins
Gross margin is 42.35%, with operating margin of -191.13%, and net profit margin of -151.71%.
Gross Margin42.35%
Operating Margin-191.13%
Pretax Margin-195.61%
Net Profit Margin-151.71%
EBITDA Margin-187.35%
EBIT Margin-191.13%
Analyst Forecast
The average price target for BioLargo is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-65.55%
EPS Growth Forecast-295.24%